DocGo (NASDAQ:DCGO) Given “Overweight” Rating at Cantor Fitzgerald

Cantor Fitzgerald reissued their overweight rating on shares of DocGo (NASDAQ:DCGO) in a research note released on Friday, Benzinga reports. They currently have a $5.00 price target on the stock.

Separately, Needham & Company LLC restated a buy rating and issued a $7.00 price target on shares of DocGo in a research note on Thursday, August 8th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of Buy and an average price target of $6.10.

DocGo Price Performance

Shares of NASDAQ:DCGO opened at $3.47 on Friday. DocGo has a 1 year low of $2.75 and a 1 year high of $6.90. The company has a market cap of $352.43 million, a PE ratio of 17.35, a P/E/G ratio of 3.02 and a beta of 0.92. The stock’s 50-day moving average is $3.50 and its 200 day moving average is $3.40.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.01). DocGo had a net margin of 3.97% and a return on equity of 8.90%. The business had revenue of $164.95 million for the quarter, compared to analysts’ expectations of $166.61 million. Analysts expect that DocGo will post 0.23 EPS for the current fiscal year.

Hedge Funds Weigh In On DocGo

Institutional investors and hedge funds have recently bought and sold shares of the stock. Point72 Asset Management L.P. increased its holdings in shares of DocGo by 1,655.7% in the second quarter. Point72 Asset Management L.P. now owns 116,844 shares of the company’s stock worth $361,000 after purchasing an additional 110,189 shares during the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of DocGo by 31.6% during the second quarter. The Manufacturers Life Insurance Company now owns 40,401 shares of the company’s stock valued at $125,000 after buying an additional 9,696 shares during the period. Marathon Capital Management boosted its position in shares of DocGo by 2.3% during the second quarter. Marathon Capital Management now owns 277,100 shares of the company’s stock valued at $856,000 after buying an additional 6,285 shares during the period. Deerfield Management Company L.P. Series C boosted its holdings in shares of DocGo by 41.0% in the second quarter. Deerfield Management Company L.P. Series C now owns 7,195,956 shares of the company’s stock valued at $22,236,000 after purchasing an additional 2,091,569 shares during the period. Finally, AQR Capital Management LLC boosted its holdings in shares of DocGo by 58.5% in the second quarter. AQR Capital Management LLC now owns 344,963 shares of the company’s stock valued at $1,066,000 after purchasing an additional 127,320 shares during the period. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.